Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease
Call: HORIZON-HLTH-2022-DISEASE-06-02: Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs
Start Date: 01/04/2023
Duration: 48
Area: Health

NEXGEN is a Horizon Europe Research and Innovation Project aiming to revolutionise the treatment and diagnosis of Parkinson’s. NEXGEN pioneers a new vaccine platform which produces substantially stronger immune responses than any existing vaccines, and develops a new diagnostic assay to detect biomarkers of Parkinson’s in blood and urine for earlier detection. Combined together, NEXGEN marks the beginning of a new generation of solutions for Parkinson’s and other non communicable diseases, substantially improving the lives of millions.